Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial-Reference-Cited by-同舟云学术

Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial

Published:2012-08-04 Issue:1 Volume:159 Page:67-77
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Knauf Wolfgang U.¹,Lissitchkov Toshko²,Aldaoud Ali³,Liberati Anna M.⁴,Loscertales Javier⁵,Herbrecht Raoul⁶,Juliusson Gunnar⁷,Postner Gerhard⁸,Gercheva Liana⁹,Goranov Stefan¹⁰,Becker Martin¹¹,Fricke Hans-Joerg¹²,Huguet Francoise¹³,Del Giudice Ilaria¹⁴,Klein Peter¹⁵,Merkle Karlheinz¹⁶,Montillo Marco¹⁷

Affiliation:

1. Onkologische Gemeinschaftspraxis; Frankfurt; Germany

2. Haematology and Transfusion Medicine; National Haematological Centre; Sofia; Bulgaria

3. Praxis für Haematologie and Onkologie; Leipzig; Germany

4. Azienda Ospidaliera Santa Maria di Terni; Universita degli Studi di Perugia; Perugia; Italy

5. Haematology; Hospital Universitario de la Princesa; Madrid; Spain

6. Oncology and Haematology; Hopital de Hautepierre; Strasbourg Cedex; France

7. Department of Haematology; Lund Stem Cell Centre; Lund; Sweden

8. Franz-Josef-Spital; LBI-ACR and ACR-ITR Vienna; Vienna; Austria

9. University Hospital for Active Treatment; Varna; Bulgaria

10. University Hospital for Active Treatment “St. George; Plovdiv; Bulgaria

11. Onkologische Schwerpunktpraxis; Porta Westphalika; Germany

12. Haematology; University Hospital; Jena; Germany

13. Department of Haematology; Hopital de Purpan; Toulouse; France

14. Division of Haematology, Department of Cellular Biotechnologies and Haematology; Sapienza University; Rome; Italy

15. Dsh Statistical Services; Rohrbach; Germany

16. Oncology Consulting; Miesbach; Germany

17. Ematologia e centro trapianti midollo osseo, Ospedale Niguarda Ca'Granda; Milano; Italy

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12000/fullpdf

Reference19 articles.

1. National cancer institute -sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment;Cheson;Blood,1996

2. Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma;Dennie;Clinical Therapeutics,2009

3. First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia;Eichhorst;Blood,2009

4. Chronic lymphocytic leukaemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Eichhorst;Annals of Oncology,2010

5. Bendamustine combined with rituximab in patients with relapsed and/or refractory chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group;Fischer;Journal of Clinical Oncology,2011

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indolente (niedrig maligne) Non-Hodgkin-Lymphome;Facharztwissen Hamatologie Onkologie;2024

2. Bendamustine-Rituximab in Young CLL: Relevance in the Era of Small Molecule Inhibitors;Indian Journal of Hematology and Blood Transfusion;2022-11-09

3. Bendamustine: a review of pharmacology, clinical use and immunological effects (Review);Oncology Reports;2022-05-03

4. Bendamustine versus chlorambucil in treatment of chronic lymphocytic leukaemia in China: a randomized, open-label, parallel-controlled, phase III clinical trial;Investigational New Drugs;2022-01-15

5. Survival, causes of death, and the prognostic role of comorbidities in chronic lymphocytic leukemia in the pre‐ibrutinib era: A population‐based study;European Journal of Haematology;2021-11-11